These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9878799)

  • 1. Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia.
    Arias RL; Tasse JR; Bowlby MR
    Brain Res; 1999 Jan; 816(2):299-308. PubMed ID: 9878799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
    Kristensen BW; Noraberg J; Zimmer J
    Brain Res; 2001 Oct; 917(1):21-44. PubMed ID: 11602227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excessive release of [3H]noradrenaline and glutamate in response to simulation of ischemic conditions in rat spinal cord slice preparation: effect of NMDA and AMPA receptor antagonists.
    Nakai T; Milusheva E; Baranyi M; Uchihashi Y; Satoh T; Vizi ES
    Eur J Pharmacol; 1999 Feb; 366(2-3):143-50. PubMed ID: 10082194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection by MK-801 against hypoxia-, excitotoxin-, and depolarization-induced neuronal damage in vitro.
    Schurr A; Payne RS; Rigor BM
    Neurochem Int; 1995 May; 26(5):519-25. PubMed ID: 7492949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous blockade of non-NMDA ionotropic receptors and NMDA receptor-associated ionophore partially protects hippocampal slices from protein synthesis impairment due to simulated ischemia.
    Virgili M; Contestabile A; Barnabei O
    Hippocampus; 1995; 5(1):91-7. PubMed ID: 7787950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effect of YM90K, an AMPA-receptor antagonist, against delayed neuronal death induced by transient global cerebral ischemia in gerbils and rats.
    Kawasaki-Yatsugi S; Yatsugi S; Koshiya K; Shimizu-Sasamata M
    Jpn J Pharmacol; 1997 Jul; 74(3):253-60. PubMed ID: 9268085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases.
    Scatton B
    Life Sci; 1994; 55(25-26):2115-24. PubMed ID: 7997070
    [No Abstract]   [Full Text] [Related]  

  • 8. Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies.
    Calabresi P; Centonze D; Cupini LM; Costa C; Pisani F; Bernardi G
    Neurobiol Dis; 2003 Feb; 12(1):82-8. PubMed ID: 12609492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats.
    Suzuki Y; Takagi Y; Nakamura R; Hashimoto K; Umemura K
    Brain Res; 2003 Feb; 964(1):116-20. PubMed ID: 12573519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-NMDA mechanism in the inhibition of cellular apoptosis and memory impairment induced by repeated ischemia in rats.
    Iwasaki K; Chung EH; Egashira N; Hatip-Al-Khatib I; Mishima K; Egawa T; Irie K; Fujiwara M
    Brain Res; 2004 Jan; 995(1):131-9. PubMed ID: 14644478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia.
    Hicks CA; Ward MA; Swettenham JB; O'Neill MJ
    Eur J Pharmacol; 1999 Sep; 381(2-3):113-9. PubMed ID: 10554878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist and an N-methyl-D-aspartate (NMDA) channel blocker synergistically impair spatial memory in rats.
    Li H; Matsumoto K; Watanabe H
    Biol Pharm Bull; 1998 Nov; 21(11):1228-30. PubMed ID: 9853420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
    Hao JX; Xu XJ
    Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous blockade of two glutamate receptor subtypes (NMDA and AMPA) results in stressor-specific inhibition of prolactin and corticotropin release.
    Zelena D; Makara GB; Jezova D
    Neuroendocrinology; 1999 May; 69(5):316-23. PubMed ID: 10343172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed preconditioning with NMDA receptor antagonists in a rat model of perinatal asphyxia.
    Makarewicz D; Sulejczak D; Duszczyk M; Małek M; Słomka M; Lazarewicz JW
    Folia Neuropathol; 2014; 52(3):270-84. PubMed ID: 25310738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral protection by AMPA- and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia.
    Nellgård B; Wieloch T
    Exp Brain Res; 1992; 92(2):259-66. PubMed ID: 1362958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.
    Takahashi M; Kohara A; Shishikura J; Kawasaki-Yatsugi S; Ni JW; Yatsugi S; Sakamoto S; Okada M; Shimizu-Sasamata M; Yamaguchi T
    CNS Drug Rev; 2002; 8(4):337-52. PubMed ID: 12481190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils.
    Montero M; Nielsen M; Rønn LC; Møller A; Noraberg J; Zimmer J
    Brain Res; 2007 Oct; 1177():124-35. PubMed ID: 17894933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia.
    O'Neill MJ; Bond A; Ornstein PL; Ward MA; Hicks CA; Hoo K; Bleakman D; Lodge D
    Neuropharmacology; 1998; 37(10-11):1211-22. PubMed ID: 9849659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.